Clinical trial · Observational
Psychosocial Screening for Neuroendocrine Tumor Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a psychosocial screening application to usual care in a cohort of neuroendocrine tumor patients. The application involves monitoring using the NCCN Distress Thermometer(DT), Hospital Anxiety and Depression Scale(HADS), Self-Perceived Burden Scale(SPBS) and Connor-Davidson Resilience Scale(CD-RISC). These assessments will be completed at baseline, 3 months, 6 months, 12 months and 24 months. Patients will have the option of filling out questionnaires more frequently if desired.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neuroendocrine Tumors | Neuroendocrine Tumor | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Neuroendocrine tumors
- description
- Patients with neuroendocrine tumors will be given access to an application that monitors distress, anxiety, depression, self-perceived burden, and resilience at regular intervals for 3 months lasting for 24 months.
Primary outcomes (1)
- measure
- DT
- timeFrame
- every 3 month until 24 month
- description
- Distress Thermometer
Secondary outcomes (3)
- measure
- HADS
- timeFrame
- every 3 month until 24 month
- description
- Hospital Anxiety and Depression Scale
- measure
- SPBS
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. sign written informed consent form; 2. age ≥ 18 years; 3. pathologically confirmed well-differentiated neuroendocrine tumors, G1-2 (Ki67≤20%); Exclusion Criteria: 1. \<18 years; 2. Neuroendocrine carcinoma; 3. History of psychiatric or psychologic illness; 4. History of previous cancers or cancer distress; 5. Patients with central nervous system(CNS) disorder; 6. Severe, uncontrolled medical condition that would affect patients' compliance;
References
Publications (0)
Data not yet available